The outcome from the SURPASS trials reveal that tirzepatide yields clinically important enhancements in glycemic Manage and weightloss when compared with other GLP-1 receptor agonists (semaglutide and dulaglutide), insulin degludec, and insulin glargine.Skip to principal content material Thanks for visiting character.com. You will be employing a b